Search

Your search keyword '"Lensvelt, M.M.A."' showing total 17 results
Start Over Author "Lensvelt, M.M.A."
17 results on '"Lensvelt, M.M.A."'

1. Cost Effectiveness of Endovascular Revascularisation vs. Exercise Therapy for Intermittent Claudication Due to Iliac Artery Obstruction

Author

Legemate, D.A., Idu, M.M., Balm, R., Reekers, J.A., van Lienden, K.P., van Delden, O.M., Zijlstra, E.J., Conijn, A.P., Dijkgraaf, M.G.W., Engelbert, R.H., De Nie, A.J., Schreve, M.A., Kropman, R.H.J., Wille, J., De Vries, J.P.M., van de Pavoort, H.D.W.M., van de Mortel, R.H.W., van den Heuvel, D.A.F., van Strijen, M.J.L., van Leersum, M., Vos, J.A., Nio, D., Rijbroek, A., Vermeulen, E.G.J., Akkersdijk, G.J.M., van de Elst, A., Truijers, M., van Kelckhoven, B.J., Leijdekkers, V.J., Vahl, A.C., Blomjous, J.G.A.M., Poyck, P.P.C., Van der Vliet, J.A., van der Jagt, M., Klemm, P.L., Willems, M.C.M., Huisman, L.C., Lensvelt, M.M.A., de Bruine, H., Mallant, M.P.J.H., Smeets, L., van Sterkenburg, S.M.M., Veendrick, P.B., van Werkum, M.H., Elsman, B.H.P., van der Hem, L.G., van Tongeren, R.B.M., Klok, C.F.M., Hellings, W.E., Wiersema, A.M., van den Broek, T.A.A., Vos, G.A., Teijink, J.A.W., van Sambeek, M.R.H.M., Keller, B.P.J.A., Glade, G.J., Breek, J.C., Gravendeel, J., Oosterhof-Berktas, R., Koedam, N.A., Hollander, E.J.F., Scharn, D.M., Lemson, M.S., Seegers, J., Krol, R.M., Blankensteijn, J.D., Hoksbergen, A.W.J., van Reijen, Nick S., van Dieren, Susan, Frans, Franceline A., Reekers, Jim A., Metz, Roderik, Buscher, Hessel C.J.L., and Koelemay, Mark J.W.

Published
2022
Full Text
View/download PDF

2. Treatment Outcome Trends for Non-Ruptured Abdominal Aortic Aneurysms: A Nationwide Prospective Cohort Study

Author

van den Akker, P.J., Akkersdijk, G.P., Akkersdijk, W.L., van Andringa de Kempenaer, M.G., Arts, C.H.P., Avontuur, A.M., Bakker, O.J., Balm, R., Barendregt, W.B., Bekken, J.A., Bender, M.H.M., Bendermacher, B.L.W., van den Berg, M., Beuk, R.J., Blankensteijn, J.D., Bode, A.S., Bodegom, M.E., van der Bogt, K.E.A., Boll, A.P.M., Booster, M.H., Borger van der Burg, B.L.S., de Borst, G.J., Bos-van Rossum, W.T.G.J., Bosma, J., Botman, J.M.J., Bouwman, L.H., Brehm, V., de Bruijn, M.T., de Bruin, J.L., Brummel, P., van Brussel, J.P., Buijk, S.E., Buimer, M.G., Buscher, H.C.J.L., Cancrinus, E., Castenmiller, P.H., Cazander, G., Cuypers, P.h.W.M., Daemen, J.H.C., Dawson, I., Dierikx, J.E., Dijkstra, M.L., Diks, J., Dinkelman, M.K., Dirven, M., Dolmans, D.E.J.G.J., van Dortmont, L.M.C., Drouven, J.W., van der Eb, M.M., Eefting, D., van Eijck, G.J.W.M., Elshof, J.W.M., Elsman, B.H.P., van der Elst, A., van Engeland, M.I.A., van Eps, G.S., Faber, M.J., de Fijter, W.M., Fioole, B., Fritschy, W.M., Jin, P.H.P.F.K., Geelkerken, R.H., van Gent, W.B., Glade, G.J., Govaert, B., Groenendijk, R.P.R., de Groot, H.G.W., van den Haak, R.F.F., de Haan, E.F.A., Hajer, G.F., Hamming, J.F., van Hattum, E.S., Hazenberg, C.E.V.B., Hedeman Joosten, P.P.h.A., Helleman, J.N., van der Hem, L.G., Hendriks, J.M., van Herwaarden, J.A., Heyligers, J.M.M., Hinnen, J.W., Hissink, R.J., Ho, G.H., den Hoed, P.T., Hoedt, M.T.C., van Hoek, F., Hoencamp, R., Hoffmann, W.H., Hoksbergen, A.W.J., Hollander, E.J.F., Huisman, L.C., Hulsebos, R.G., Huntjens, K.M.B., Idu, M.M., Jacobs, M.J.H.M., van der Jagt, M.F.P., Jansbeken, J.R.H., Janssen, R.J.L., Jiang, H.H.L., de Jong, S.C., Jongbloed-Winkel, T.A., Jongkind, V., Kapma, M.R., Keller, B.P.J.A., Jahrome, A.K., Kievit, J.K., Klemm, P.L., Klinkert jr, P., Koedam, N.A., Koelemaij, M.J.W., Kolkert, J.L.P., Koning, G.G., Koning, O.H.J., Konings, R., Krasznai, A.G., Kropman, R.H.J., Kruse, R.R., van der Laan, L., van der Laan, M.J., van Laanen, J.H.H., van Lammeren, G.W., Lamprou, D.A.A., Lardenoije, J.H.P., Lauret, G.J., Leenders, B.J.M., Legemate, D.A., Leijdekkers, V.J., Lemson, M.S., Lensvelt, M.M.A., Lijkwan, M.A., van der Linden, F.T.h.P.M., Lung, P.F. Liqui, Loos, M.J.A., Loubert, M.C., van de Luijtgaarden, K.M., Mahmoud, D.E.A.K., Manshanden, C.G., Mattens, E.C.J.L., Meerwaldt, R., Mees, B.M.E., Menting, T.P., Metz, R., de Mol van Otterloo, J.C.A., Molegraaf, M.J., Montauban van Swijndregt, Y.C.A., Morak, M.J.M., van de Mortel, R.H.W., Mulder, W., Nagesser, S.K., Naves, C.C.L.M., Nederhoed, J.H., Nevenzel, A.M., de Nie, A.J., Nieuwenhuis, D.H., van Nieuwenhuizen, R.C., Nieuwenhuizen, J., Nio, D., Oomen, A.P.A., Oranen, B.I., Oskam, J., Palamba, H.W., Peppelenbosch, A.G., van Petersen, A.S., Petri, B.J., Pierie, M.E.N., Ploeg, A.J., Pol, R.A., Ponfoort, E.D., Poyck, P.P.C., Prent, A., Raa, S. ten, Raymakers, J.T.F.J., Reichmann, B.L., Reijnen, M.M.P.J., de Ridder, J.A.M., Rijbroek, A., van Rijn, M.J.E., de Roo, R.A., Rouwet, E.V., Saleem, B.R., van Sambeek, M.R.H.M., Samyn, M.G., van ’t Sant, H.P., van Schaik, J., van Schaik, P.M., Scharn, D.M., Scheltinga, M.R.M., Schepers, A., Schlejen, P.M., Schlösser, F.J.V., Schol, F.P.G., Scholtes, V.P.W., Schouten, O., Schreve, M.A., Schurink, G.W.H., Sikkink, C.J.J.M., Slaa, A. te, Smeets, H.J., Smeets, L., Smeets, R.R., de Smet, A.A.E.A., Smit, P.C., Smits, T.M., Snoeijs, M.G.J., Sondakh, A.O., Speijers, M.J., van der Steenhoven, T.J., van Sterkenburg, S.M.M., Stigter, D.A.A., Stokmans, R.A., Strating, R.P., Stultiëns, G.N.M., Sybrandy, J.E.M., Teijink, J.A.W., Telgenkamp, B.J., Testroote, M.J.G., Tha-In, T., The, R.M., Thijsse, W.J., Thomassen, I., Tielliu, I.F.J., van Tongeren, R.B.M., Toorop, R.J., Tournoij, E., Truijers, M., Türkcan, K., Tutein Nolthenius, R.P., Ünlü, C., Vaes, R.H.D., Vahl, A.C., Veen, E.J., Veger, H.T.C., Veldman, M.G., Verhagen, H.J.M., Verhoeven, B.A.N., Vermeulen, C.F.W., Vermeulen, E.G.J., Vierhout, B.P., van der Vijver-Coppen, R.J., Visser, M.J.T., van der Vliet, J.A., van Vlijmen - van Keulen, C.J., van der Vorst, J.R., Vos, A.W.F., Vos, C.G., Vos, G.A., de Vos, B., Voûte, M.T., Vriens, B.H.R., Vriens, P.W.H.E., de Vries, D.K., de Vries, J.P.P.M., de Vries, M., de Vries, A.C., van der Waal, C., Waasdorp, E.J., Wallis de Vries, B.M., van Walraven, L.A., van Wanroi, J.L., Warlé, M.C., van Weel, V., van Well, A.M.E., Welten, G.M.J.M., Wever, J.J., Wiersema, A.M., Wikkeling, O.R.M., Willaert, W.I.M., Wille, J., Willems, M.C.M., Willigendael, E.M., Wilschut, E.D., Wisselink, W., Witte, M.E., Wittens, C.H.A., Wong, C.Y., Yazar, O., Yeung, K.K., Zeebregts, C.J.A.M., van Zeeland, M.L.P., Alberga, Anna J., Karthaus, Eleonora G., Wilschut, Janneke A., de Bruin, Jorg L., Akkersdijk, George P., Geelkerken, Robert H., Hamming, Jaap F., Wever, Jan J., and Verhagen, Hence J.M.

Published
2022
Full Text
View/download PDF

3. Cost Effectiveness of Endovascular Revascularisation vs. Exercise Therapy for Intermittent Claudication Due to Iliac Artery Obstruction

Author

van Reijen, Nick S., primary, van Dieren, Susan, additional, Frans, Franceline A., additional, Reekers, Jim A., additional, Metz, Roderik, additional, Buscher, Hessel C.J.L., additional, Koelemay, Mark J.W., additional, Legemate, D.A., additional, Idu, M.M., additional, Balm, R., additional, Reekers, J.A., additional, van Lienden, K.P., additional, van Delden, O.M., additional, Zijlstra, E.J., additional, Conijn, A.P., additional, Dijkgraaf, M.G.W., additional, Engelbert, R.H., additional, De Nie, A.J., additional, Schreve, M.A., additional, Kropman, R.H.J., additional, Wille, J., additional, De Vries, J.P.M., additional, van de Pavoort, H.D.W.M., additional, van de Mortel, R.H.W., additional, van den Heuvel, D.A.F., additional, van Strijen, M.J.L., additional, van Leersum, M., additional, Vos, J.A., additional, Nio, D., additional, Rijbroek, A., additional, Vermeulen, E.G.J., additional, Akkersdijk, G.J.M., additional, van de Elst, A., additional, Truijers, M., additional, van Kelckhoven, B.J., additional, Leijdekkers, V.J., additional, Vahl, A.C., additional, Blomjous, J.G.A.M., additional, Poyck, P.P.C., additional, Van der Vliet, J.A., additional, van der Jagt, M., additional, Klemm, P.L., additional, Willems, M.C.M., additional, Huisman, L.C., additional, Lensvelt, M.M.A., additional, de Bruine, H., additional, Mallant, M.P.J.H., additional, Smeets, L., additional, van Sterkenburg, S.M.M., additional, Veendrick, P.B., additional, van Werkum, M.H., additional, Elsman, B.H.P., additional, van der Hem, L.G., additional, van Tongeren, R.B.M., additional, Klok, C.F.M., additional, Hellings, W.E., additional, Wiersema, A.M., additional, van den Broek, T.A.A., additional, Vos, G.A., additional, Teijink, J.A.W., additional, van Sambeek, M.R.H.M., additional, Keller, B.P.J.A., additional, Glade, G.J., additional, Breek, J.C., additional, Gravendeel, J., additional, Oosterhof-Berktas, R., additional, Koedam, N.A., additional, Hollander, E.J.F., additional, Scharn, D.M., additional, Lemson, M.S., additional, Seegers, J., additional, Krol, R.M., additional, Blankensteijn, J.D., additional, and Hoksbergen, A.W.J., additional

Published
2022
Full Text
View/download PDF

4. Treatment Outcome Trends for Non-Ruptured Abdominal Aortic Aneurysms: A Nationwide Prospective Cohort Study

Author

Alberga, Anna J., primary, Karthaus, Eleonora G., additional, Wilschut, Janneke A., additional, de Bruin, Jorg L., additional, Akkersdijk, George P., additional, Geelkerken, Robert H., additional, Hamming, Jaap F., additional, Wever, Jan J., additional, Verhagen, Hence J.M., additional, van den Akker, P.J., additional, Akkersdijk, G.P., additional, Akkersdijk, W.L., additional, van Andringa de Kempenaer, M.G., additional, Arts, C.H.P., additional, Avontuur, A.M., additional, Bakker, O.J., additional, Balm, R., additional, Barendregt, W.B., additional, Bekken, J.A., additional, Bender, M.H.M., additional, Bendermacher, B.L.W., additional, van den Berg, M., additional, Beuk, R.J., additional, Blankensteijn, J.D., additional, Bode, A.S., additional, Bodegom, M.E., additional, van der Bogt, K.E.A., additional, Boll, A.P.M., additional, Booster, M.H., additional, Borger van der Burg, B.L.S., additional, de Borst, G.J., additional, Bos-van Rossum, W.T.G.J., additional, Bosma, J., additional, Botman, J.M.J., additional, Bouwman, L.H., additional, Brehm, V., additional, de Bruijn, M.T., additional, de Bruin, J.L., additional, Brummel, P., additional, van Brussel, J.P., additional, Buijk, S.E., additional, Buimer, M.G., additional, Buscher, H.C.J.L., additional, Cancrinus, E., additional, Castenmiller, P.H., additional, Cazander, G., additional, Cuypers, P.h.W.M., additional, Daemen, J.H.C., additional, Dawson, I., additional, Dierikx, J.E., additional, Dijkstra, M.L., additional, Diks, J., additional, Dinkelman, M.K., additional, Dirven, M., additional, Dolmans, D.E.J.G.J., additional, van Dortmont, L.M.C., additional, Drouven, J.W., additional, van der Eb, M.M., additional, Eefting, D., additional, van Eijck, G.J.W.M., additional, Elshof, J.W.M., additional, Elsman, B.H.P., additional, van der Elst, A., additional, van Engeland, M.I.A., additional, van Eps, G.S., additional, Faber, M.J., additional, de Fijter, W.M., additional, Fioole, B., additional, Fritschy, W.M., additional, Jin, P.H.P.F.K., additional, Geelkerken, R.H., additional, van Gent, W.B., additional, Glade, G.J., additional, Govaert, B., additional, Groenendijk, R.P.R., additional, de Groot, H.G.W., additional, van den Haak, R.F.F., additional, de Haan, E.F.A., additional, Hajer, G.F., additional, Hamming, J.F., additional, van Hattum, E.S., additional, Hazenberg, C.E.V.B., additional, Hedeman Joosten, P.P.h.A., additional, Helleman, J.N., additional, van der Hem, L.G., additional, Hendriks, J.M., additional, van Herwaarden, J.A., additional, Heyligers, J.M.M., additional, Hinnen, J.W., additional, Hissink, R.J., additional, Ho, G.H., additional, den Hoed, P.T., additional, Hoedt, M.T.C., additional, van Hoek, F., additional, Hoencamp, R., additional, Hoffmann, W.H., additional, Hoksbergen, A.W.J., additional, Hollander, E.J.F., additional, Huisman, L.C., additional, Hulsebos, R.G., additional, Huntjens, K.M.B., additional, Idu, M.M., additional, Jacobs, M.J.H.M., additional, van der Jagt, M.F.P., additional, Jansbeken, J.R.H., additional, Janssen, R.J.L., additional, Jiang, H.H.L., additional, de Jong, S.C., additional, Jongbloed-Winkel, T.A., additional, Jongkind, V., additional, Kapma, M.R., additional, Keller, B.P.J.A., additional, Jahrome, A.K., additional, Kievit, J.K., additional, Klemm, P.L., additional, Klinkert jr, P., additional, Koedam, N.A., additional, Koelemaij, M.J.W., additional, Kolkert, J.L.P., additional, Koning, G.G., additional, Koning, O.H.J., additional, Konings, R., additional, Krasznai, A.G., additional, Kropman, R.H.J., additional, Kruse, R.R., additional, van der Laan, L., additional, van der Laan, M.J., additional, van Laanen, J.H.H., additional, van Lammeren, G.W., additional, Lamprou, D.A.A., additional, Lardenoije, J.H.P., additional, Lauret, G.J., additional, Leenders, B.J.M., additional, Legemate, D.A., additional, Leijdekkers, V.J., additional, Lemson, M.S., additional, Lensvelt, M.M.A., additional, Lijkwan, M.A., additional, van der Linden, F.T.h.P.M., additional, Lung, P.F. Liqui, additional, Loos, M.J.A., additional, Loubert, M.C., additional, van de Luijtgaarden, K.M., additional, Mahmoud, D.E.A.K., additional, Manshanden, C.G., additional, Mattens, E.C.J.L., additional, Meerwaldt, R., additional, Mees, B.M.E., additional, Menting, T.P., additional, Metz, R., additional, de Mol van Otterloo, J.C.A., additional, Molegraaf, M.J., additional, Montauban van Swijndregt, Y.C.A., additional, Morak, M.J.M., additional, van de Mortel, R.H.W., additional, Mulder, W., additional, Nagesser, S.K., additional, Naves, C.C.L.M., additional, Nederhoed, J.H., additional, Nevenzel, A.M., additional, de Nie, A.J., additional, Nieuwenhuis, D.H., additional, van Nieuwenhuizen, R.C., additional, Nieuwenhuizen, J., additional, Nio, D., additional, Oomen, A.P.A., additional, Oranen, B.I., additional, Oskam, J., additional, Palamba, H.W., additional, Peppelenbosch, A.G., additional, van Petersen, A.S., additional, Petri, B.J., additional, Pierie, M.E.N., additional, Ploeg, A.J., additional, Pol, R.A., additional, Ponfoort, E.D., additional, Poyck, P.P.C., additional, Prent, A., additional, Raa, S. ten, additional, Raymakers, J.T.F.J., additional, Reichmann, B.L., additional, Reijnen, M.M.P.J., additional, de Ridder, J.A.M., additional, Rijbroek, A., additional, van Rijn, M.J.E., additional, de Roo, R.A., additional, Rouwet, E.V., additional, Saleem, B.R., additional, van Sambeek, M.R.H.M., additional, Samyn, M.G., additional, van ’t Sant, H.P., additional, van Schaik, J., additional, van Schaik, P.M., additional, Scharn, D.M., additional, Scheltinga, M.R.M., additional, Schepers, A., additional, Schlejen, P.M., additional, Schlösser, F.J.V., additional, Schol, F.P.G., additional, Scholtes, V.P.W., additional, Schouten, O., additional, Schreve, M.A., additional, Schurink, G.W.H., additional, Sikkink, C.J.J.M., additional, Slaa, A. te, additional, Smeets, H.J., additional, Smeets, L., additional, Smeets, R.R., additional, de Smet, A.A.E.A., additional, Smit, P.C., additional, Smits, T.M., additional, Snoeijs, M.G.J., additional, Sondakh, A.O., additional, Speijers, M.J., additional, van der Steenhoven, T.J., additional, van Sterkenburg, S.M.M., additional, Stigter, D.A.A., additional, Stokmans, R.A., additional, Strating, R.P., additional, Stultiëns, G.N.M., additional, Sybrandy, J.E.M., additional, Teijink, J.A.W., additional, Telgenkamp, B.J., additional, Testroote, M.J.G., additional, Tha-In, T., additional, The, R.M., additional, Thijsse, W.J., additional, Thomassen, I., additional, Tielliu, I.F.J., additional, van Tongeren, R.B.M., additional, Toorop, R.J., additional, Tournoij, E., additional, Truijers, M., additional, Türkcan, K., additional, Tutein Nolthenius, R.P., additional, Ünlü, C., additional, Vaes, R.H.D., additional, Vahl, A.C., additional, Veen, E.J., additional, Veger, H.T.C., additional, Veldman, M.G., additional, Verhagen, H.J.M., additional, Verhoeven, B.A.N., additional, Vermeulen, C.F.W., additional, Vermeulen, E.G.J., additional, Vierhout, B.P., additional, van der Vijver-Coppen, R.J., additional, Visser, M.J.T., additional, van der Vliet, J.A., additional, van Vlijmen - van Keulen, C.J., additional, van der Vorst, J.R., additional, Vos, A.W.F., additional, Vos, C.G., additional, Vos, G.A., additional, de Vos, B., additional, Voûte, M.T., additional, Vriens, B.H.R., additional, Vriens, P.W.H.E., additional, de Vries, D.K., additional, de Vries, J.P.P.M., additional, de Vries, M., additional, de Vries, A.C., additional, van der Waal, C., additional, Waasdorp, E.J., additional, Wallis de Vries, B.M., additional, van Walraven, L.A., additional, van Wanroi, J.L., additional, Warlé, M.C., additional, van Weel, V., additional, van Well, A.M.E., additional, Welten, G.M.J.M., additional, Wever, J.J., additional, Wiersema, A.M., additional, Wikkeling, O.R.M., additional, Willaert, W.I.M., additional, Wille, J., additional, Willems, M.C.M., additional, Willigendael, E.M., additional, Wilschut, E.D., additional, Wisselink, W., additional, Witte, M.E., additional, Wittens, C.H.A., additional, Wong, C.Y., additional, Yazar, O., additional, Yeung, K.K., additional, Zeebregts, C.J.A.M., additional, and van Zeeland, M.L.P., additional

Published
2022
Full Text
View/download PDF

5. Association of Hospital Volume with Perioperative Mortality of Endovascular Repair of Complex Aortic Aneurysms

Author

Alberga, Anna J., von Meijenfeldt, Gerdine C.I., Rastogi, Vinamr, de Bruin, Jorg L., Wever, Jan J., van Herwaarden, Joost A., Hamming, Jaap F., Hazenberg, Constantijn E.V.B., van Schaik, Jan, Mees, Barend M.E., van der Laan, Maarten J., Zeebregts, Clark J., Schurink, Geert W.H., Verhagen, Hence J.M., van den Akker, PJ., Akkersdijk, G.P., Akkersdijk, W.L., van Andringa de Kempenaer, M.G., Arts, C.H.P., Avontuur, A.M., Bakker, O.J., Balm, R., Barendregt, W.B., Bekken, J.A., Bender, M.H.M., Bendermacher, B.L.W., van den Berg, M., Beuk, R.J., Blankensteijn, ., Bodegom, M.E., Bogt, van der, Boll, A.P.M., Booster, M.H., Burg, Borger van der, de Borst, G.J., Rossum, Bos-van, Bosma, J., Botman, J.M.J., Bouwman, L.H., Brehm, V., de Bruijn, M.T., de Bruin, J.L., Brummel, P., Brussel, van, Buijk, S.E., Buimer, M.G., Buscher, Cancrinus, E., Castenmiller, P.H., Cazander, G., Cuypers, Ph.W.M., Daemen, J.H.C., Dawson, I., Dierikx, J.E., Dijkstra, M.L., Diks, J., Dinkelman, M.K., Dirven, M., Dolmans, D.E.J.G.J., van Dortmont, L.M.C., Drouven, J.W., van der Eb, M.M., Eefting, D., Eijck, van, Elshof, J.W.M., Elsman, A.H.P., van der Elst, A., van Engeland, M.I.A., van Eps, G.S., Faber, M.J., de Fijter, W.M., Fioole, B., Fritschy, W.M., Fung Kon Jin, P.H.P., Geelkerken, R.H., van Gent, W.B., Glade, G.J., Govaert, B., Groenendijk, R.P.R., de Groot, H.G.W., van den Haak, R.F.F., de Haan, E.F.A., Hajer, G.F., Hamming, J.F., van Hattum, E.S., Hazenberg, C.E.VB., Hedeman Joosten, P.Ph.A., Helleman, J.N., van der Hem, L.G., Hendriks, J.M., van Herwaarden, J.A., Heyligers, J.M.M., Hinnen, J.W., Hissink, R.J., Ho, G.H., den Hoed, P.T., Hoedt, M.T.C., van Hoek, F., Hoencamp, R., Hoffmann, W.H., Hoksbergen, A.W.J., Hollander, E.J.F., Huisman, L.C., Hulsebos, R.G., Huntjens, K.M.B., Idu, M.M., Jacobs, M.J.H.M., van der Jagt, M.F.P., Jansbeken, J.R.H., Janssen, R.J.L., Jiang, H.H.L., de Jong, S.C., Jongbloed-Winkel, T.A., Jongkind, V., Kapma, M.R., Keller, B.PJ.A., Jahrome, A. Khodadade, Kievit, J.K., Klemm, P.L., Klinkert, Koedam, N.A., Koelemaij, M.J.W., Kolkert, J.L.P., Koning, G.G., Koning, O.H.J., Konings, R., Krasznai, A.G., Kropman, R.H.J., Kruse, R.R., van der Laan, L., van der Laan, M.J., van Laanen, J.H.H., van Lammeren, G.W., Lamprou, D.A.A., Lardenoije, J.H.P., Lauret, G.J., Leenders, B.J.M., Legemate, Leij- dekkers, V.J., Lemson, M.S., Lensvelt, M.M.A., Lijkwan, M.A., van der Linden, F.Th.P.M., Lung, P.F. Liqui, Loos, M.J.A., Loubert, M.C., Luijtgaarden, van de, Mahmoud, D.E.A.K., Manshanden, C.G., Mat- tens, E.C.J.L., Meerwaldt, R., Mees, B.M.E., Menting, T.P., Metz, R., de Mol van Otterloo, J.C.A., Molegraaf, M.J., Montauban van Swijn- dregt, Y.C.A., Morak, M.J.M., van de Mortel, R.H.W., Mulder, W., Nagesser, S.K., Naves, C.C.L.M., Nederhoed, J.H., Nevenzel, A.M., de Nie, A.J., Nieuwenhuis, D.H., van Nieuwenhuizen, R.C., Nieuwenhui- zen, J., Nio, D., Oomen, A.P.A., Oranen, B.I., Oskam, J., Palamba, H.W., Peppelenbosch, A.G., van Petersen, A.S., Petri, ., Pierie, M.E.N., Ploeg, A.J., Pol, R.A., Ponfoort, E.D., Poyck, P.P.C., Prent, A., ten Raa, S., Raymakers, J.T.F.J., Reichmann, B.L., Reijnen, M.M.P.J., de Ridder, J.A.M., Rijbroek, A., van Rijn, M.J.E., de Roo, R.A., Rouwet, E.V., Saleem, B.R., van Sambeek, M.R.H.M., Samyn, M.G., van’t Sant, H.P., van Schaik, J., van Schaik, PM., Scharn, ., Scheltinga, M.R.M., Schepers, A., Schlejen, P.M., Schlösser, F.J. V., Schol, F.P.G., Scholtes, V.P.W, Schouten, O., Schreve, M.A., Schurink, G.W.H., Sikkink, C.J.J.M., te Slaa, A., Smeets, H.J., Smeets, L., Smeets, R.R., de Smet, A.A.E.A., Smit, PC., Smits, T.M., Snoeijs, M.G.J., Sondakh, A.O., Speijers, M.J., van der Steenhoven, T.J., van Sterkenburg, S.M.M., Stigter, D.A.A., Stokmans, R.A., Strating, R.P, Stultiëns, G.N.M., Sybrandy, J.E.M., Teijink, J.A.W., Telgenkamp, ., Testroote, M.J.G., Tha-In, T., The, R.M., Thijsse, W.J., Thomassen, I., Tielliu, I.F.J., van Tongeren, R.B.M., Toorop, R.J., Tournoij, E., Truijers, M., Türkcan, K., Nolthenius, R.P. Tutein, Ünlü, C., Vaes, R.H.D., Vahl, A.C., Veen, E.J., Veger, H.T.C., Veldman, M.G., Verhagen, H.J.M., Verhoeven, B.A.N., Vermeulen, C.F.W., Vermeulen, E.G.J., Vierhout, B.P., Coppen, van der Vijver-, Visser, M.J.T., van der Vliet, J.A., van Vlijmen-van Keulen, C.J., van der Vorst, J.R., Vos, A.W.F., Vos, C.G., Vos, G.A., de Vos, B., Voûte, M.T., Vriens, B.H.R., Vriens, P.W.H.E., de Vries, D.K., de Vries, J.P.P.M., de Vries, M., de Vries, A.C., van der Waal, C., Waasdorp, E.J., Wallis de Vries, ., van Walraven, L.A., van Wanroi, J.L., Warlé, M.C., van Weel, V, van Well, A.M.E., Welten, G.M.J.M., Wever, J.J., Wiersema, A.M., Wikkeling, O.R.M., Willaert, W.I.M., Wille, J., Willems, M.C.M., Willigendael, E.M., Wilschut, E.D., Wisselink, W., Witte, M.E., Wittens, C.H.A., Wong, C.Y., Yazar, O., Yeung, K.K., Zeebregts, C.J.A.M., and van Zeeland, M.L.P.

Published
2023
Full Text
View/download PDF

6. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis

Author

Doomernik, D.E., Golchehr, B., Lensvelt, M.M.A., and Reijnen, M.M.P.J.

Subjects
Evaluation of complex medical interventions [NCEBP 2]
Abstract

Item does not contain fulltext AIM: Results of endovascular treatment for long de novo lesions of the superficial femoral artery (SFA) are limited by in-stent restenosis (ISR). Polytetrafluoroethylene (PTFE) covered stents are developed to reduce the incidence of ISR. This study was conducted to summarize available data on the use of endoprosthesis in the treatment of SFA occlusive disease and to evaluate their use in the treatment of ISR. METHODS: A systematic literature search was performed, using MEDLINE, EMBASE and Cochrane databases. Reports on the application of Hemobahn(R) and Viabahn(R) endoprosthesis in the treatment of long de-novo lesions and ISR of the SFA were included. RESULTS: A total of 19 articles were included. Technical success rates varied between 95-100%. Case series have shown 1-year primary patency rates varying between 44% and 86%, with secondary patency rates between 58% and 93%. Large differences in patient and lesion characteristics, medical therapy and developments in stent-graft design complicate comparisons between studies. Randomized studies have shown a superiority of the endoprosthesis above angioplasty only and similar patency rates with above-knee prosthetic femoro-popliteal bypass up to 48 months. Data on the use of endografts for ISR are scarce. CONCLUSION: The use of an endoprosthesis for SFA occlusive disease is an effective and safe treatment strategy for long de novo lesions. Patient selection and adequate medical support appear to be important in achieving long term patency. Data focusing on the effectiveness of endoprosthesis for ISR are still limited. 01 augustus 2012

Published
2012

7. Treatment strategies for extensive chronic SFA occlusions: indications and results

Author

Lensvelt, M.M.A., Reijnen, M.M.P.J., Wallis de Vries, B.M., and Zeebregts, C.J.A.

Subjects
Evaluation of complex medical interventions [NCEBP 2]
Abstract

Item does not contain fulltext Treatment modalities for extensive chronic occlusive disease of the superficial femoral artery (SFA) have changed during the last decades. In this chapter we provide an overview of current treatment modalities for extensive chronic occlusive disease of the SFA. Although the autologous venous conduit is still considered the gold standard for treatment of long occlusive SFA lesions, endoluminal therapy is gaining territory. Its' minimal invasive character has great advantages in the frail vascular patient population. Percutaneous transluminal angioplasty is first choice in short SFA lesions, but patency rates decrease with longer lesions. When percutaneous transluminal angioplasty is combined with nitinol stent placement patency rates significantly improve. Patency rates of percutaneous transluminal angioplasty combined with covered stents are within reach of patency rates of prosthetic surgical bypasses. Drug-bonding in surgical PTFE bypasses increased patency rates significantly. In the near future drug-eluting and drug-bonded devices might further increase results of endovascular treatment. 01 februari 2012

Published
2012

8. Three-year outcome of the heparin-bonded Viabahn for superficial femoral artery occlusive disease

Author

Golchehr, B., Kruse, R., Walraven, L.A. van, Lensvelt, M.M.A., Zeebregts, C.J.A., Reijnen, M.M.P.J., Golchehr, B., Kruse, R., Walraven, L.A. van, Lensvelt, M.M.A., Zeebregts, C.J.A., and Reijnen, M.M.P.J.

Abstract

Item does not contain fulltext, OBJECTIVE: Self-expanding covered stents for superficial femoral artery (SFA) occlusive disease have undergone an evolution during the years. Early results of the latest generation, the heparin-bonded Viabahn (W. L. Gore & Associates, Flagstaff, Ariz) with a contoured proximal edge, were promising, with reported 1-year primary patency rates of 73% to 78% in long lesions. The aim of this study was to present the 3-year outcome of the heparin-bonded Viabahn for SFA occlusive disease. METHODS: All patients treated with a heparin-bonded Viabahn in three centers between April 2009 and December 2011 were included in the study and retrospectively analyzed. Clinical state in Rutherford category, ankle-brachial indexes, and duplex ultrasound scans were the features of follow-up at 6 weeks and 6, 12, 24, and 36 months. Primary end points of the study were the 3-year primary, primary assisted, and secondary patency rates. RESULTS: A total of 73 SFAs in 70 patients were treated with a heparin-bonded Viabahn and included in the study. Fifty-four patients were male (77%), and the mean age was 70.0 +/- 9.1 years. The mean lesion length was 17.4 +/- 7.0 cm, and 84% were classified TransAtlantic Inter-Society Consensus II types C and D. The median follow-up was 25 months (range, 2-55 months). The 3-year primary, primary assisted, and secondary patency rates were 59%, 71%, and 82%, respectively, with a 3-year freedom from amputation of 100%. CONCLUSIONS: The use of a heparin-bonded Viabahn for SFA occlusive disease is related to patency rates within limits of surgical reconstruction. The procedure is related to low morbidity and amputation rates.

Published
2015

9. The outcome of failed endografts inserted for superficial femoral artery occlusive disease

Author

Lensvelt, M.M.A., Golchehr, B., Kruse, R.R., Holewijn, S., Walraven, L.A. van, Fritschy, W.M., Zeebregts, C.J.A., Reijnen, M.M.P.J., Lensvelt, M.M.A., Golchehr, B., Kruse, R.R., Holewijn, S., Walraven, L.A. van, Fritschy, W.M., Zeebregts, C.J.A., and Reijnen, M.M.P.J.

Abstract

Item does not contain fulltext, OBJECTIVE: Endografts represent a relatively new treatment modality for occlusive disease of the superficial femoral artery, with promising results. However, endografts may occlude collateral arteries, which may affect outcome in case of failure. The purpose of this study was to analyze the clinical outcome of failed endografts in patients with superficial femoral artery occlusive disease. METHODS: All patients treated with one or more polytetrafluorethylene-covered stents between November 2001 and December 2011 were prospectively included in a database. Patients with a failure of the endograft were retrospectively analyzed. Clinical and hemodynamic parameters were assessed before the initial procedure and at the time of failure. Outcome of secondary procedures was analyzed. RESULTS: Among the 341 patients who were treated during the study period, 49 (14.4%) failed during follow-up. Mean (standard deviation) Rutherford category at failure did not differ from the category as scored before the initial procedure (3.1 [1.3] vs 3.3 [0.6]; P = .33). Forty-three percent of patients (n = 21) presented with the same Rutherford category as before the initial procedure, 37% (n = 18) with an improved category, and 20% (n = 10) with a deteriorated category. The ankle-brachial index was significantly lower at the time of failure (0.66 [0.19] vs 0.45 [0.19[; P <.002). Seventy-six percent of patients with a failure needed secondary surgery, of which 25% were below knee. The 1-year primary, primary-assisted, and secondary patency rates of secondary bypasses were 55.1%, 62.3%, and 77.7%, respectively. The amputation rate was 4.1% (n = 2). CONCLUSIONS: Failure of endografts is not associated with a deterioration in clinical state and is related to a low amputation rate. The hypothesis that covered stents do not affect options for secondary reconstructions could not be confirmed, as 25% of patients with a failure underwent a below-knee bypass. Secondary surgical bypasses are correlated

Published
2013

10. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery.

Author

Lensvelt, M.M.A., Wikkeling, O.R., Oostayen, J.A., Roukema, J.G., Zeebregts, C.J.A., Reijnen, M.M.P.J., Lensvelt, M.M.A., Wikkeling, O.R., Oostayen, J.A., Roukema, J.G., Zeebregts, C.J.A., and Reijnen, M.M.P.J.

Abstract

1 mei 2012, Item does not contain fulltext, Redo femoropopliteal bypass surgery is associated with increased morbidity and related to a poorer outcome than primary procedures. Endografts might provide an alternative, avoiding dissection of a previously operated groin. Patients treated with a polytetrafluoroethylene-covered stents for superficial femoral artery occlusive disease between February 2009 and September 2011 were prospectively gathered. Demographics, clinical status, procedural aspects, and follow-up were retrieved. Seventy-four patients were included of which 5 (7%) were treated before with a femoropopliteal bypass. Indication for intervention was Rutherford category 3 in all patients and the median ankle-brachial index (ABI) was 0.68. Technical success was achieved in all cases. The postoperative course was uneventful in all and the ABI increased to 0.95. After a follow-up period of 18 months, 4 of 5 endografts remained patent. The use of endografts after failed femoropopliteal bypass surgery is feasible and safe and could be used to avoid or minimize a difficult and hazardous dissection of a previously operated area.

Published
2012

11. Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease.

Author

Lensvelt, M.M.A., Fritschy, W.M., Oostayen, J.A., Holewijn, S., Zeebregts, C.J.A., Reijnen, M.M.P.J., Lensvelt, M.M.A., Fritschy, W.M., Oostayen, J.A., Holewijn, S., Zeebregts, C.J.A., and Reijnen, M.M.P.J.

Abstract

1 juli 2012, Item does not contain fulltext, OBJECTIVE: The purpose of this study was to assess the 1-year patency rates of heparin-bonded covered stents in the treatment of chronic occlusive disease of the superficial femoral artery (SFA). METHODS: All patients treated with a heparin-bonded endograft between April 2009 and October 2010 for chronic occlusive disease of the SFA were prospectively gathered in a database and retrospectively analyzed. Primary, primary-assisted, and secondary patency rates, assessed by ultrasound scanning, were analyzed at 1-year, as were the complication rates and mortality. RESULTS: A total of 56 limbs were treated with a heparin-bonded covered stent in 53 patients for chronic ischemia Rutherford category 3 (n = 36), 4 (n = 5), 5 (n = 11), and 6 (n = 1). Lesions were classified as TransAtlantic Inter-Society Consensus (TASC)-2-B (n = 9), C (n = 14), and D (n = 33), and the mean treated lesion length was 18.5 +/- 7.7 cm. Postoperative complications occurred in 7.5%, including hematoma (n = 1), edema (n = 1), pneumonia (n = 1), and urinary retention (n = 1), and the 30-day mortality rate was 0%. The mean follow-up was 413 +/- 208 days. At 1 year, the primary patency was 76%, the primary-assisted patency 82%, and the secondary patency 89%. The limb salvage rate was 100%. CONCLUSIONS: Heparin-bonded covered stents seem to provide a valid alternative to surgical treatment of long occlusive lesions in the SFA. Randomized trials and long-term data are required before considering the technique as a new standard of care.

Published
2012

12. The combined ipsilateral antegrade-retrograde approach to insert an endoluminal femoropopliteal bypass

Author

Lensvelt, M.M.A., Zeebregts, C.J.A., Stoer-Bouwman, M., Reijnen, M.M.P.J., Lensvelt, M.M.A., Zeebregts, C.J.A., Stoer-Bouwman, M., and Reijnen, M.M.P.J.

Abstract

Item does not contain fulltext, The endoluminal femoropopliteal bypass is a minimally invasive treatment modality for occlusive superficial femoral artery disease. Technical failure of endovascular treatment of chronic total occlusions is often caused by the inability to re-enter the true lumen. Re-entry devices have a high technical success-rate, but increased procedural costs. We describe an alternative technique using an ipsilateral combined antegrade-retrograde approach to insert an endoluminal femoropopliteal bypass. In a supine position, with the leg elevated at 30 degrees, the popliteal artery is punctured and a 4F introducer sheath is introduced. The occlusion is crossed from distal to proximal and the wire is advanced through a 6F sheath that is positioned in the common femoral artery. The occlusion is predilated from proximal and the "re-entry" site is identified on an angiogram. The wire is then withdrawn into the balloon catheter and advanced intraluminally into one of the crural vessels. After confirming the intraluminal position of the wire, the 4F sheath is removed, and the endoluminal bypass is created in a standardized fashion. The ipsilateral antegrade-retrograde approach is a fast, inexpensive, and easy-to-learn technique, using standard materials only. The distal entry of the occlusion will lead to a minimization of the length of the endoluminal bypass, thereby possibly sparing collaterals and future surgical options.

Published
2011

13. SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial

Author

Lensvelt, M.M.A., Holewijn, S., Fritschy, W.M., Wikkeling, O.R., Walraven, L.A. van, Wallis de Vries, B.M., Zeebregts, C.J.A., Reijnen, M.M.P.J., Lensvelt, M.M.A., Holewijn, S., Fritschy, W.M., Wikkeling, O.R., Walraven, L.A. van, Wallis de Vries, B.M., Zeebregts, C.J.A., and Reijnen, M.M.P.J.

Abstract

Contains fulltext : 96315.pdf (publisher's version ) (Open Access), BACKGROUND: Endovascular treatment options for the superficial femoral artery are evolving rapidly. For long lesions, the venous femoropopliteal bypass considered to be superior above the prosthetic bypass. An endoluminal bypass, however, may provide equal patency rates compared to the prosthetic above knee bypass. The introduction of heparin-bonded endografts may further improve patency rates. The SUrgical versus PERcutaneous Bypass (SuperB) study is designed to assess whether a heparin-bonded endoluminal bypass provides equal patency rates compared to the venous bypass and to prove that it is associated with improved quality of life, related to a decreased complication rate, or not. METHODS/DESIGN: Two-hundred-twenty-two patients with peripheral arterial occlusive disease, category 3-6 according to Rutherford, will be randomized in two treatment arms; 1. the surgical femoro-popliteal bypass, venous whenever possible, and 2. the heparin-bonded endoluminal bypass. The power analysis was based on a non-inferiority principle, with an effect size of 90% and 10% margins (alpha 5%, power 80%). Patients will be recruited from 5 teaching hospitals in the Netherlands during a 2-year period. The primary endpoint is primary patency and quality of life evaluated by the RAND-36 questionnaire and the Walking Impairment Questionnaire. Secondary endpoints include secondary patency, freedom-from-TLR and complications. DISCUSSION: The SuperB trial is a multicentre randomized controlled trial designed to show non-inferiority in patency rates of the heparin-bonded endograft compared to the surgical bypass for treatment of long SFA lesions, and to prove a better quality of life using the heparin bonded-endograft compared to surgically treatment, related to a reduction in complications. TRIAL REGISTRATION: Clinicaltrials: NCT01220245.

Published
2011

14. Peritoneal changes due to laparoscopic surgery.

Author

Brokelman, W.J., Lensvelt, M.M.A., Borel Rinkes, I.H.M., Klinkenbijl, J.H.G., Reijnen, M.M.P.J., Brokelman, W.J., Lensvelt, M.M.A., Borel Rinkes, I.H.M., Klinkenbijl, J.H.G., and Reijnen, M.M.P.J.

Abstract

1 januari 2011, Item does not contain fulltext, BACKGROUND: Laparoscopic surgery has been incorporated into common surgical practice. The peritoneum is an organ with various biologic functions that may be affected in different ways by laparoscopic and open techniques. Clinically, these alterations may be important in issues such as peritoneal metastasis and adhesion formation. METHODS: A literature search using the Pubmed and Cochrane databases identified articles focusing on the key issues of laparoscopy, peritoneum, inflammation, morphology, immunology, and fibrinolysis. Results : Laparoscopic surgery induces alterations in the peritoneal integrity and causes local acidosis, probably due to peritoneal hypoxia. The local immune system and inflammation are modulated by a pneumoperitoneum. Additionally, the peritoneal plasmin system is inhibited, leading to peritoneal hypofibrinolysis. CONCLUSION: Similar to open surgery, laparoscopic surgery affects both the integrity and biology of the peritoneum. These observations may have implications for various clinical conditions.

Published
2011

15. Decreased peritoneal expression of active transforming growth factor ss1 during laparoscopic cholecystectomy with heated carbon dioxide.

Author

Lensvelt, M.M.A., Ivarsson, M.L., Brokelman, W.J., Falk, P., Reijnen, M.M.P.J., Lensvelt, M.M.A., Ivarsson, M.L., Brokelman, W.J., Falk, P., and Reijnen, M.M.P.J.

Abstract

1 oktober 2010, Item does not contain fulltext, BACKGROUND: Laparoscopic surgery involves the establishment of a pneumoperitoneum, mostly using carbon dioxide. Cooling of the peritoneum, due to insufflation, may traumatize the peritoneum and disturb local biological processes. The current study was performed to assess the effect of the temperature of carbon dioxide on peritoneal transforming growth factor beta1 (TGF-beta1) expression. DESIGN: Patients were randomized into 2 groups. In one group, a pneumoperitoneum was created with carbon dioxide at room temperature; in the other, with carbon dioxide at body temperature. Peritoneal biopsy specimens were taken at the start and end of surgery. SETTING: Community hospital. PATIENTS: Thirty patients scheduled for laparoscopic cholecystectomy. MAIN OUTCOME MEASURES: Tissue concentrations of total and active TGF-beta1 were measured using enzyme-linked immunosorbent assays. Results : At the start of surgery, there were no significant differences between groups in the total and active fractions of TGF-beta1. At the end of the procedure, the peritoneal active TGF-beta1 concentrations were significantly lower (P = .03) in patients receiving carbon dioxide at body temperature. In contrast, the concentrations of total TGF-beta1 did not differ between groups. A slight, nonsignificant increase in total and active TGF-beta1 levels was observed in patients receiving unheated carbon dioxide. The ratio of active to total TGF-beta1 did not change during procedures, and there were no differences between groups. CONCLUSIONS: Heating of carbon dioxide, used for insufflation, to body temperature decreases the expression of active TGF-beta1 in the peritoneum. Considering the broad biological effects of TGF-beta1, including the regulation of peritoneal healing and oncological processes, this observation might have clinical repercussions.

Published
2010

16. Peritoneal transforming growth factor beta-1 expression during prolonged laparoscopic procedures.

Author

Lensvelt, M.M.A., Brokelman, W.J., Ivarsson, M.L., Falk, P., Reijnen, M.M.P.J., Lensvelt, M.M.A., Brokelman, W.J., Ivarsson, M.L., Falk, P., and Reijnen, M.M.P.J.

Abstract

Item does not contain fulltext, BACKGROUND: Laparoscopic surgery may affect peritoneal physiology. Short-term laparoscopic surgery does not affect peritoneal transforming growth factor beta (TGF-b1) expression. The current study was conducted to evaluate the hypothesis that prolonged laparoscopic surgery may affect peritoneal TGF-b1 expression. STUDY DESIGN: In the first study, 24 patients scheduled for a right colonic resection were enrolled in the trial. Twelve underwent conventional surgery (CCR) and 12 were operated on laparoscopically (LCR). In the second study, 12 patients undergoing laparoscopic gastric bypass (LGB) surgery for morbid obesity were included. Biopsies of the parietal peritoneum were taken at standardized moments during the procedures. Tissue concentrations of active and total TGF-b1 were measured by using enzyme-linked immunosorbent assays. Results : During the LCR, there was a significant increase in peritoneal active TGF-b1 levels (P < 0.05). A similar, but not significant, trend was observed during the CCR. A similar pattern was seen in the total TGF-b1 concentrations during both procedures. The LGB procedure did not affect peritoneal active or total TGF-b1 concentrations. During the procedure, both the active and total TGF-b1 levels were significantly higher in the LCR, when compared to the LGB, group (P < 0.05). CONCLUSIONS: Prolonged laparoscopic surgery may affect peritoneal TGF-b1 expression, depending on the procedure performed. Considering the role of TGF-b1 in various biologic processes, including adhesiogenesis and oncology, these results may have clinical consequences.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results